DOI QR코드

DOI QR Code

Upregulation of Nitric Oxide Synthase Activity by All-trans Retinoic Acid and 13-cis Retinoic Acid in Human Malignant Keratinocytes

  • Moon, Ki-Young (BioMedicinal Chemistry Laboratory, Department of Clinical Pathology, Gwangju Health University)
  • Received : 2019.05.22
  • Accepted : 2019.06.18
  • Published : 2019.06.30

Abstract

Effect of retinoids, i.e., all-trans retinoic acid and 13-cis retinoic acid, on the activity of nitric oxide synthase (NOS) was evaluated in human malignant keratinocytes to examine the possible correlation of retinoids with NOS activities. All-trans retinoic acid and 13-cis retinoic acid did not alter the nitric oxide (NO) production. However, in the presence of lipopolysaccharide (LPS, $1{\mu}g/mL$), they significantly increased NO release in a dose-dependent manner until 48 h at concentrations of $50{\sim}100{\mu}M$. The degree of upregulation of NO by all-trans retinoic acid and 13-cis retinoic acid increased up to 35% and 37%, respectively, compared to that by the control, which demonstrated the upregulation of LPS-inducible nitric oxide synthase (iNOS)-dependent generation of NO as well as showing a crucial link between retinoids-induced activity and NOS. Findings of this study now suggest that the upregulation of LPS-iNOS activity may be associated with modulation of retinoids-induced control of cellular developmental processes, which may produce new therapeutics of retinoids in the complexity of how NO affects human keratinocytes.

Keywords

References

  1. Altucci L, Gronemeyer H. The promise of retinoids to fight against cancer. Nature Reviews Cancer. 2001. 1: 181-193. https://doi.org/10.1038/35106036
  2. Aranda E, Lopez-Pedrera C, De La Haba-Rodriguez JR, Rodriguez-Ariza A. Nitric oxide and cancer: the emerging role of S nitrosylation. Current Molecular Medicine. 2012. 11: 50-67.
  3. Beckenbach L, Baron JM, Merk HF, Loffler H, Amann PM. Retinoid treatment of skin diseases. European Journal of Dermatology. 2015. 5: 384-391.
  4. Becherel PA, Chosidow O, Le Goff L, Frances C, Debre P, Mossalayi MD, Arock M. Inducible nitric oxide synthase and proinflammatory cytokine expression by human keratinocytes during acute urticaria. Molecular Medicine. 1997. 3: 686-694. https://doi.org/10.1007/BF03401707
  5. Becherel PA, Le Goff L, Ktorza S, Ouaaz F, Mencia-Huerta JM, Dugas B, Debre P, Mossalayi MD, Arock M. Interleukin-10 inhibits IgE-mediated nitric oxide synthase induction and cytokine synthesis in normal human keratinocytes. European Journal of Immunology. 1995. 25: 2992-2995. https://doi.org/10.1002/eji.1830251042
  6. Brune B, von Knethen A, Sandau KB. Nitric oxide (NO): an effector of apoptosis. Cell Death and Differentiation. 1999. 6: 969-975. https://doi.org/10.1038/sj.cdd.4400582
  7. Carratu MR, Marasco C, Mangialardi G, Vacca A. Retinoids: novel immunomodulators and tumour-suppressive agents? British Journal of Pharmacology. 2012. 167: 483-492. https://doi.org/10.1111/j.1476-5381.2012.02031.x
  8. Chen YK, Hsue SS, Lin LM. Increased expression of inducible nitric oxide synthase for human buccal squamous-cell carcinomas: immunohistochemical, reverse transcription-polymerase chain reaction (RT-PCR) and in situ RT-PCR studies. Head Neck. 2002. 24: 925-932. https://doi.org/10.1002/hed.10131
  9. Cinel L, Polat A, Aydin O, Dusmez D, Egilmez R. Bcl-2, iNOS, p53 and PCNA expression in normal, disordered proliferative, hyperplastic and malignant endometrium. Pathology International. 2002. 52: 384-389. https://doi.org/10.1046/j.1440-1827.2002.01358.x
  10. Darwiche N, Bazzi H, El-Touni L, Abou-Lteif G, Doueiri R, Hatoum A, Maalouf S, Gali-Muhtasib H. Regulation of ultraviolet B radiation-mediated activation of AP1 signaling by retinoids in primary keratinocytes. Radiation Research. 2005. 163: 296-306. https://doi.org/10.1667/RR3318
  11. Ertesvag A, Naderi S, Blomhoff HK. Regulation of B cell proliferation and differentiation by retinoic acid. Seminars in Immunology. 2009. 21: 36-41. https://doi.org/10.1016/j.smim.2008.06.005
  12. Freemantle SJ, Spinella MJ, Dmitrovsky E. Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene. 2003. 22: 7305-7315. https://doi.org/10.1038/sj.onc.1206936
  13. Harada K, Supriatno, Kawaguchi S, Tomitaro O, Yoshida H, Sato M. Overexpression of iNOS gene suppresses the tumorigenicity and metastasis of oral cancer cells. In Vivo. 2004. 18: 449-455.
  14. Heck DE, Laskin DL, Gardner CR, Laskin JD. Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing. Journal of Biological Chemistry. 1992. 267: 21277-21280. https://doi.org/10.1016/S0021-9258(19)36601-3
  15. Hickok JR, Thomas DD. Nitric oxide and cancer therapy: the emperor has NO clothes. Current Pharmaceutical Design. 2010. 16: 381-391. https://doi.org/10.2174/138161210790232149
  16. Jun CD, Pae HO, Yoo JC, Kwak HJ, Park RK, Chung HT. Cyclic adenosine monophosphate inhibits nitric oxide-induced apoptosis in human leukemic HL-60 cells. Cellular Immunology. 1998. 183: 13-21. https://doi.org/10.1006/cimm.1997.1232
  17. Kambhampati S, Li Y, Verma A, Sassano A, Majchrxak B, Deb DK, Parmar S, Giafis N, Kalvakolanu DV, Rahman A, Uddin S, Minucci S, Tallman MS, Fish EN, Platanias LC. Activation of protein kinase C delta by all-trans-retinoic acid. Journal of Biological Chemistry. 2003. 278: 32544-32551. https://doi.org/10.1074/jbc.M301523200
  18. Lechner M, Lirk P, Rieder J. Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. Seminars in Cancer Biology. 2005. 11: 277-289. https://doi.org/10.1006/scbi.2001.0383
  19. Lippman SM, Kessler JF, Meyskens FL Jr. Retinoids as preventive and therapeutic anticancer agents (Part I). Cancer Treatment Reports. 1987. 71: 391-405.
  20. Lippman SM, Meyskens FL Jr. Treatment of advanced squamous cell carcinoma of the skin with isotretinoin. Annals of Internal Medicine. 1987. 107: 499-502. https://doi.org/10.7326/0003-4819-107-4-499
  21. Lotan R. Retinoids in cancer chemoprevention. FASEB Journal. 1996. 10: 1031-1039. https://doi.org/10.1096/fasebj.10.9.8801164
  22. Messmer UK, Lapetina EG, Brune B. Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds. Molecular Pharmacology. 1995. 47: 757-765.
  23. Moon KY. The chemopreventive effect of retinoids on cellular $NF-{\kappa}B$ activity induced by NMU and NEU in human malignant keratinocytes. Cancer Research and Treatment. 2007. 39: 82-87. https://doi.org/10.4143/crt.2007.39.2.82
  24. Moon KY. Acrolein, an $I-{\kappa}B{\alpha}-independent$ downregulation of $NF-{\kappa}B$ activity, causes the decrease in nitric oxide production in human malignant keratinocytes. Archives of Toxicology. 2011. 85: 499-504. https://doi.org/10.1007/s00204-010-0599-4
  25. Moon KY. N-nitroso-N-methylurea and N-nitroso-N-ethylurea decrease in nitric oxide production in human malignant keratinocytes. Biomedical Science Letters. 2018. 24: 50-54. https://doi.org/10.15616/BSL.2018.24.1.50
  26. Niles RM. The use of retinoids in the prevention and treatment of skin cancer. Expert Opinion Pharmacotherapy. 2002. 3: 299-303. https://doi.org/10.1517/14656566.3.3.299
  27. Okuno M, Kojima S, Matsushima-Nishiwaki R, Tsurumi H, Muto Y, Friedman SL, Moriwaki H. Retinoids in cancer chemoprevention. Current Cancer Drug Targets. 2004. 4: 285-298. https://doi.org/10.2174/1568009043333023
  28. Ozel E, Pestereli HE, Simsek T, Erdogan G, Karaveli FS. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in ovarian surface epithelial carcinomas: is there any correlation with angiogenesis or clinicopathologic parameters? International Journal of Gynecological Cancer. 2006. 16: 549-555.
  29. Reveneau S, Arnould L, Jolimoy G, Hilpert S, Lejeune P, Saint-Giorgio V, Belichard C, Jeannin JF. Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors. Laboratory Investigation. 1999. 79: 1215-1225.
  30. Ridnour LA, Thomas DD, Switzer C, Flores-Santana W, Isenberg JS, Ambs S, Roberts DD, Wink DA. Molecular mechanisms for discrete nitric oxide levels in cancer. Nitric Oxide. 2008. 19: 73-76. https://doi.org/10.1016/j.niox.2008.04.006
  31. Rudkin GH, Carlsen BT, Chung CY, Huang W, Ishida K, Anvar B, Yamaguchi DT, Miller TA. Retinoids inhibit squamous cell carcinoma growth and intercellular communication. Journal of Surgical Research. 2002. 103: 183-189. https://doi.org/10.1006/jsre.2001.6346
  32. Uruno A, Sugawara A, Kanatsuka H, Kagechika H, Saito A, Sato K, Kudo M, Takeuchi K, Ito S. Upregulation of nitric oxide production in vascular endothelial cells by all-trans retinoic acid through the phosphoinositide 3-kinase/Akt pathway. Circulation. 2005. 112: 727-736. https://doi.org/10.1161/CIRCULATIONAHA.104.500959